Scientific Advisory Board
Commercial Partners 2022
Commercial Partners 2021
Commercial Partners 2020
Note to exhibitors
Host a Webinar
Bispecifics Drug Product Development; Challenge of Low Concentration Analysis and Formulation
11:50 - 12:25
Glenmark’s BEAT format – advantages, flexibilities, applicability etc.
Formulation and stability aspects of bispecifics.
Strategies to overcome analytical and formulation challenges for a highly potent molecule.
Preparation for clinical trials for extremely low FIH starting dose.
Back to programme
© Copyright MA Exhibitions 2022
Part of the
Mark Allen Group